CLINICAL_TRIALS
trial_result
· 2019-03-13
Clinical Trial Update: A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis (RA) [Phase 3]
Summary
Phase 3 trial update for baricitinib in rheumatoid arthritis has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2019-03-13